0 12 min 2 weeks

The global “Oncology Drugs Market” is expected to reach USD 394.24 billion by 2027, exhibiting a CAGR of 11.6% during the forecast period. The growing prevalence of cancer around the world will spur opportunities for this market during the forecast period, states Fortune Business Insights, in a report, titled “Oncology Drugs Market Size, Share &COVID-19 Impact Analysis, By Drugs Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, and Others), By Dosage Form (Solid, Liquid, and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and Regional Forecast, 2020-2027.” The market size stood at USD 141.33 billion in 2019.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/oncology-drugs-market-103431

The oncology drugs market highlights:

  • An extensivestudy of regions
  • Forecast value of the market
  • Detailed analysis ofthe segments
  • COVID-19 effect on the market
  • Ongoing clinical trials

Positive Impact on Oncology Drugs Market Growth During COVID-19

The outbreak of COVID-19 has had a positive impact on the oncology drugs market globally. Certain market segments have witnessed a growth in demand for drugs with respect to the COVID-19 emergency. Panic buying of medications has been witnessed among the cancer patients amid lockdown. The pharmaceutical companies involved in this market have significantly improved their supply chain management, enhanced the capabilities of their R&D, and invested more their manufacturing management and quality control. For instance, according to the quarterly reports of 2020 of Roche, their global supply chain of medicines and tests remain intact and their pharmaceutical division sales increased by 7% as compared to the prior year.

Quick Buy –  Oncology Drugs Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/103431

The Report Lists the Main Companies in the Market:

  • Hoffmann-La Roche Ltd (Basel, Switzerland)
  • Genentech, Inc. (California, United States)
  • Novartis AG (Basel, Switzerland)
  • Pfizer Inc. (New York, United States)
  • Bristol-Myers Squibb Company (New York, United States)
  • GlaxoSmithKline plc. (Brentford, United Kingdom)
  • Eli Lilly and Company (Indiana, United States)
  • AstraZeneca (Cambridge, United Kingdom)
  • Sanofi (Paris, France)
  • Bayer AG (Leverkusen, Germany)
  • Other Players

Positive Impact on Oncology Drugs Market Growth During COVID-19

The outbreak of COVID-19 has had a positive impact on the oncology drugs market globally. Certain market segments have witnessed a growth in demand for drugs with respect to the COVID-19 emergency. Panic buying of medications has been witnessed among the cancer patients amid lockdown. The pharmaceutical companies involved in this market have significantly improved their supply chain management, enhanced the capabilities of their R&D, and invested more their manufacturing management and quality control. For instance, according to the quarterly reports of 2020 of Roche, their global supply chain of medicines and tests remain intact and their pharmaceutical division sales increased by 7% as compared to the prior year.

Key Development:

April 2019: Sun Pharmaceutical Industries announced the release of INFUGEM injection, which will ve used for the treatment of cancer in the US.

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/oncology-drugs-market-103431

Global Oncology Drugs Market Segmentation :

By Drug Class

  • Cytotoxic Drugs
  • Alkylating Agents
  • Antimetabolites
  • Others
  • Targeted Drugs
  • Monoclonal Antibodies
  • Others
  • Hormonal Drugs
  • Others

By Therapy

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy

By Indication

  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Others

By Dosage Form

  • Solid
  • Tablets
  • Capsules
  • Liquid
  • Injectable
  • Prefilled Syringes
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Geography

  • North America (the U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and the Rest of the Middle East & Africa)

Table of Content:

1 Oncology Drugs Market Overview

1.1 Oncology Drugs Product Overview

1.2 Oncology Drugs Market Segment by Type

1.3 Global Oncology Drugs Market Size by Type (2015-2027)

1.3.1 Global Oncology Drugs Market Size Overview by Type (2015-2027)

1.3.2 Global Oncology Drugs Historic Market Size Review by Type (2015-2021)

1.3.2.1 Global Oncology Drugs Sales Market Share Breakdown by Type (2015-2027)

1.3.2.2 Global Oncology Drugs Market Share Breakdown by Type (2015-2027)

1.3.2.3 Global Oncology Drugs Average Selling Price (ASP) by Type (2015-2027)

1.3.3 Global Oncology Drugs Market Size Forecast by Type (2021-2027)

1.3.3.1 Global Oncology Drugs Sales Market Share Breakdown by Application (2021-2027)

1.3.3.2 Global Oncology Drugs Revenue Market Share Breakdown by Application (2021-2027)

1.3.3.3 Global Oncology Drugs Average Selling Price (ASP) by Application (2021-2027)

1.4 Key Regions Market Size Segment by Type (2015-2021)

1.4.1 North America Oncology Drugs Sales Breakdown by Type (2015-2027)

1.4.2 Europe Oncology Drugs Sales Breakdown by Type (2015-2027)

1.4.3 Asia-Pacific Oncology Drugs Sales Breakdown by Type (2015-2027)

1.4.4 Latin America Oncology Drugs Sales Breakdown by Type (2015-2027)

1.4.5 Middle East and Africa Oncology Drugs Sales Breakdown by Type (2015-2027)

2 Global Oncology Drugs Market Competition by Company

2.1 Global Top Players by Oncology Drugs Sales (2015-2021)

2.2 Global Top Players by Oncology Drugs Revenue (2015-2021)

2.3 Global Top Players Oncology Drugs Average Selling Price (ASP) (2015-2021)

2.4 Global Top Company Oncology Drugs Manufacturing Base Distribution, Sales Area, Product Type

2.5 Oncology Drugs Market Competitive Situation and Trends

2.5.1 Oncology Drugs Market Growth Rate (2015-2021)

2.5.2 Global 5 and 10 Largest Company by Oncology Drugs Sales and Revenue in 2019

2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drugs as of 2019)

2.7 Date of Key Company Enter into Oncology Drugs Market

2.8 Key Company Oncology Drugs Product Offered

2.9 Mergers and Acquisitions, Expansion

3 Global Oncology Drugs Status and Outlook by Region (2015-2027)

3.1 Global Oncology Drugs Market Size and CAGR by Region: 2015 VS 2021 VS 2027

3.2 Global Oncology Drugs Market Size Market Share by Region (2015-2021)

3.2.1 Global Oncology Drugs Sales Market Share by Region (2015-2021)

3.2.2 Global Oncology Drugs Revenue Market Share by Region (2015-2021)

3.2.3 Global Oncology Drugs Sales, Revenue, Price and Gross Margin (2015-2021)

3.3 Global Oncology Drugs Market Size Market Share by Region (2021-2027)

3.3.1 Global Oncology Drugs Sales Market Share by Region (2021-2027)

3.3.2 Global Oncology Drugs Revenue Market Share by Region (2021-2027)

3.3.3 Global Oncology Drugs Sales, Revenue, Price and Gross Margin (2021-2027)

3.4 North America Oncology Drugs Market Size By Growth (2015-2027)

3.4.1 North America Oncology Drugs Revenue By Growth (2015-2027)

3.4.2 North America Oncology Drugs Sales By Growth (2015-2027)

3.5 Asia-Pacific Oncology Drugs Market Size By Growth (2015-2027)

3.5.1 Asia-Pacific Oncology Drugs Revenue By Growth (2015-2027)

3.5.2 Asia-Pacific Oncology Drugs Sales By Growth (2015-2027)

3.6 Europe Oncology Drugs Market Size By Growth (2015-2027)

3.6.1 Europe Oncology Drugs Revenue By Growth (2015-2027)

3.6.2 Europe Oncology Drugs Sales By Growth (2015-2027)

3.7 Latin America Oncology Drugs Market Size By Growth (2015-2027)

3.7.1 Latin America Oncology Drugs Revenue By Growth (2015-2027)

3.7.2 Latin America Oncology Drugs Sales By Growth (2015-2027)

3.8 Middle East and Africa Oncology Drugs Market Size By Growth (2015-2027)

3.8.1 Middle East and Africa Oncology Drugs Revenue By Growth (2015-2027)

3.8.2 Middle East and Africa Oncology Drugs Sales By Growth (2015-2027)

4 Global Oncology Drugs by Application

4.1 Oncology Drugs Segment by Application

4.1.1 Residential

4.1.2 Commercial

4.2 Global Oncology Drugs Sales by Application: 2015 VS 2021 VS 2027

4.3 Global Oncology Drugs Historic Sales by Application (2015-2021)

4.4 Global Oncology Drugs Forecasted Sales by Application (2021-2027)

4.5 Key Regions Oncology Drugs Market Size by Application

4.5.1 North America Oncology Drugs by Application

4.5.2 Europe Oncology Drugs by Application

4.5.3 Asia-Pacific Oncology Drugs by Application

4.5.4 Latin America Oncology Drugs by Application

4.5.5 Middle East and Africa Oncology Drugs by Application

5 North America Oncology Drugs Market Size by Country (2015-2027)

5.1 North America Market Size Market Share by Country (2015-2021)

5.1.1 North America Oncology Drugs Sales Market Share by Country (2015-2021)

5.1.2 North America Oncology Drugs Revenue Market Share by Country (2015-2021)

5.2 North America Market Size Market Share by Country (2021-2027)

5.2.1 North America Oncology Drugs Sales Market Share by Country (2021-2027)

5.2.2 North America Oncology Drugs Revenue Market Share by Country (2021-2027)

5.3 North America Market Size By Growth by Country

5.3.1 U.S. Oncology Drugs Market Size By Growth (2015-2027)

5.3.2 Canada Oncology Drugs Market Size By Growth (2015-2027)

6 Europe Oncology Drugs Market Size by Country (2015-2027)

6.1 Europe Market Size Market Share by Country (2015-2021)

6.1.1 Europe Oncology Drugs Sales Market Share by Country (2015-2021)

6.1.2 Europe Oncology Drugs Revenue Market Share by Country (2015-2021)

6.2 Europe Market Size Market Share by Country (2021-2027)

6.2.1 Europe Oncology Drugs Sales Market Share by Country (2021-2027)

6.2.2 Europe Oncology Drugs Revenue Market Share by Country (2021-2027)

6.3 Europe Market Size By Growth by Country

6.3.1 Germany Oncology Drugs Market Size By Growth (2015-2027)

6.3.2 France Oncology Drugs Market Size By Growth (2015-2027)

6.3.3 U.K. Oncology Drugs Market Size By Growth (2015-2027)

6.3.4 Italy Oncology Drugs Market Size By Growth (2015-2027)

6.3.5 Russia Oncology Drugs Market Size By Growth (2015-2027)

7 Asia-Pacific Oncology Drugs Market Size by Country (2015-2027)

7.1 Asia-Pacific Market Size Market Share by Country (2015-2021)

7.1.1 Asia-Pacific Oncology Drugs Sales Market Share by Country (2015-2021)

7.1.2 Asia-Pacific Oncology Drugs Revenue Market Share by Country (2015-2021)

7.2 Asia-Pacific Market Size Market Share by Country (2021-2027)

7.2.1 Asia-Pacific Oncology Drugs Sales Market Share by Country (2021-2027)

7.2.2 Asia-Pacific Oncology Drugs Revenue Market Share by Country (2021-2027)

7.3 Asia-Pacific Market Size By Growth by Country

7.3.1 China Oncology Drugs Market Size By Growth (2015-2027)

7.3.2 Japan Oncology Drugs Market Size By Growth (2015-2027)

7.3.3 South Korea Oncology Drugs Market Size By Growth (2015-2027)

7.3.4 India Oncology Drugs Market Size By Growth (2015-2027)

7.3.5 Australia Oncology Drugs Market Size By Growth (2015-2027)

7.3.6 Taiwan Oncology Drugs Market Size By Growth (2015-2027)

7.3.7 Indonesia Oncology Drugs Market Size By Growth (2015-2027)

7.3.8 Thailand Oncology Drugs Market Size By Growth (2015-2027)

7.3.9 Malaysia Oncology Drugs Market Size By Growth (2015-2027)

7.3.10 Philippines Oncology Drugs Market Size By Growth (2015-2027)

Toc Continue…

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]

LinkedIn: https://www.linkedin.com/company/fortune-business-insights

Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd

 

Related Reports:

Pharmacy Benefit Management Market

Pharmacy Benefit Management Market Size

Pharmacy Benefit Management Market Share

Pharmacy Benefit Management Market Trends

Pharmacy Benefit Management Market Growth

Pharmacy Benefit Management Market Analysis

Pharmacy Benefit Management Market Business Opportunities

Pharmacy Benefit Management Market Key Players

Pharmacy Benefit Management Market Demand

Pharmacy Benefit Management Market Competitive Landscape

Pharmacy Benefit Management Market Segments

Pharmacy Benefit Management Market Overview

Pharmacy Benefit Management Industry

Pharmacy Benefit Management Market Stastistic

Pharmacy Benefit Management Market Devlopment Strategy

Pharmacy Benefit Management Market Future Growth

Pharmacy Benefit Management Market Research Methodology

Pharmacy Benefit Management Market Drivers

Pharmacy Benefit Management Market Manufacturers

Pharmacy Benefit Management Market Revenue

Pharmacy Benefit Management Market Growth Analysis

Pharmacy Benefit Management Market Search Analysis

Pharmacy Benefit Management Market Condition

Pharmacy Benefit Management Market Covid Effect

Pharmacy Benefit Management Market CAGR Value

Leave a Reply

Your email address will not be published. Required fields are marked *